Article
Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factors.
PloS one - 30 Nov 2010
Saludes Verónica, Bracho Maria Alma, Valero Oliver, Ardèvol Mercè, Planas Ramón, González-Candelas Fernando, Ausina Vicente, Martró Elisa
Abstract excerpt
BACKGROUND: Current treatment of chronic hepatitis C virus (HCV) infection has limited efficacy -especially among genotype 1 infected patients-, is costly, and involves severe side effects. Thus, predicting non-response is of major interest for both patient wellbeing and health care expense. At p...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.